Janina Beha
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion.
Journal: Frontiers in oncology
Published: November 13, 2024
Standardized Response Assessment in Patients with Advanced Cholangiocarcinoma Treated with Personalized Therapy.
Journal: Journal of personalized medicine
Published: September 23, 2024
The German Network for Personalized Medicine to enhance patient care and translational research.
Journal: Nature medicine
Published: June 06, 2023
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
Journal: Neuro-oncology advances
Published: March 14, 2023
The molecular tumor board
Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
Published: August 18, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.
Journal: NPJ precision oncology
Published: December 18, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options.
Journal: JCO precision oncology
Published: January 31, 2020
ClinVAP: a reporting strategy from variants to therapeutic options.
Journal: Bioinformatics (Oxford, England)
Published: April 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026